- Tytuł:
- Cardiovascular Eligibility Criteria and Adverse Event Reporting in Combined Immune Checkpoint and VEGF Inhibitor Trials
Czasopismo naukowe
- Tytuł:
- Cardiovascular Eligibility Criteria and Adverse Event Reporting in Combined Immune Checkpoint and VEGF Inhibitor Trials
- Autorzy:
- Źródło:
- In JACC: CardioOncology April 2024 6(2):267-279
Czasopismo naukowe